October 2026 - Corcept Therapeutics

Relacorilant Provides Significant Benefit Across Cardiometabolic Outcomes in Global Statistical Tests of the Placebo-controlled, Randomized-withdrawal GRACE Trial in Cushing Syndrome

October 16, 2026

Hand et al. • 2026 • CMHC

Characteristics Associated With Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disorders: Analyses From the MOMENTUM Study

October 8, 2026

Al Dhaybi et al. • 2026 • AHA HTN